Signaling involved in pituitary adenylate cyclase-activating polypeptide-stimulated ADNP expression

Peptides

Volumn 27, Issue 7, 2006, Pages 1859-1864

  Nakamachi, Tomoya ^a,b   Li, Min ^a   Shioda, Seiji ^a,b   Arimura, Akira ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ADNP; Mouse; Neuron glia co culture; PACAP; Signal transduction

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACTIVITY DEPENDENT NEUROTROPHIC PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NEUROTROPHIC FACTOR; PHOSPHOLIPASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COCULTURE; CONTROLLED STUDY; GLIA; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; COCULTURE TECHNIQUES; ENZYME INHIBITORS; HOMEODOMAIN PROTEINS; MAP KINASE SIGNALING SYSTEM; MICE; NERVE TISSUE PROTEINS; NEUROGLIA; NEURONS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 33744978998     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.01.007     Document Type: Article

References (30)

1. Arimura A. Perspectives on pituitary adenylate cyclase-activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn J Physiol 48 (1998) 301-331
2. Arimura A., Somogyvari-Vigh A., Weill C., Fiore R.C., Tatsuno I., Bay V., et al. PACAP functions as a neurotrophic factor. Ann N Y Acad Sci 739 (1994) 228-243
3. Ashur-Fabian O., Giladi E., Brenneman D.E., and Gozes I. Identification of VIP/PACAP receptors on rat astrocytes using antisense oligodeoxynucleotides. J Mol Neurosci 9 (1997) 211-222
4. Banks W.A., Uchida D., Arimura A., Somogyvari-Vigh A., and Shioda S. Transport of pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier and the prevention of ischemia-induced death of hippocampal neurons. Ann N Y Acad Sci 805 (1996) 270-277 (discussion 277-279)
5. Bassan M., Zamostiano R., Davidson A., Pinhasov A., Giladi E., Perl O., et al. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J Neurochem 72 (1999) 1283-1293
6. Brenneman D.E., Hauser J.M., Spong C., and Phillips T.M. Chemokine release is associated with the protective action of PACAP-38 against HIV envelope protein neurotoxicity. Neuropeptides 36 (2002) 271-280
7. Brenneman D.E., Neale E.A., Foster G.A., d'Autremont S.W., and Westbrook G.L. Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide. J Cell Biol 104 (1987) 1603-1610
8. Brenneman D.E., Westbrook G.L., Fitzgerald S.P., Ennist D.L., Elkins K.L., Ruff M.R., et al. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335 (1988) 639-642
9. 2+ and phospholipase C. Brain Res 958 (2002) 43-51
10. Gozes I., Zamostiano R., Pinhasov A., Bassan M., Giladi E., Steingart R.A., et al. A novel VIP responsive gene. Activity dependent neuroprotective protein. Ann N Y Acad Sci 921 (2000) 115-118
11. Gressens P. VIP neuroprotection against excitotoxic lesions of the developing mouse brain. Ann N Y Acad Sci 897 (1999) 109-124
12. Grimaldi M., and Cavallaro S. Functional and molecular diversity of PACAP/VIP receptors in cortical neurons and type I astrocytes. Eur J Neurosci 11 (1999) 2767-2772
13. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R., et al. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 50 (1998) 265-270
14. Hashimoto H., Kunugi A., Arakawa N., Shintani N., Fujita T., Kasai A., et al. Possible involvement of a cyclic AMP-dependent mechanism in PACAP-induced proliferation and ERK activation in astrocytes. Biochem Biophys Res Commun 311 (2003) 337-343
15. Kong L.Y., Maderdrut J.L., Jeohn G.H., and Hong J.S. Reduction of lipopolysaccharide-induced neurotoxicity in mixed cortical neuron/glia cultures by femtomolar concentrations of pituitary adenylate cyclase-activating polypeptide. Neuroscience 91 (1999) 493-500
16. Li M., David C., Kikuta T., Somogyvari-Vigh A., and Arimura A. Signaling cascade involved in neuroprotection by subpicomolar pituitary adenylate cyclase-activating polypeptide 38. J Mol Neurosci 27 (2005) 91-105
17. Masmoudi O., Gandolfo P., Leprince J., Vaudry D., Fournier A., Patte-Mensah C., et al. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates endozepine release from cultured rat astrocytes via a PKA-dependent mechanism. Faseb J 17 (2003) 17-27
18. McCulloch D.A., MacKenzie C.J., Johnson M.S., Robertson D.N., Holland P.J., Ronaldson E., et al. Additional signals from VPAC/PAC family receptors. Biochemical Society Transactions 30 (2002) 441-446
19. Mercer A., Ronnholm H., Holmberg J., Lundh H., Heidrich J., Zachrisson O., et al. PACAP promotes neural stem cell proliferation in adult mouse brain. J Neurosci Res 76 (2004) 205-215
20. Onoue S., Endo K., Ohshima K., Yajima T., and Kashimoto K. The neuropeptide PACAP attenuates β-amyloid (1-42)-induced toxicity in PC12 cells. Peptides 23 (2002) 1471-1478
21. Pinhasov A., Mandel S., Torchinsky A., Giladi E., Pittel Z., Goldsweig A.M., et al. Activity-dependent neuroprotective protein: a novel gene essential for brain formation. Brain Res Dev Brain Res 144 (2003) 83-90
22. Sherwood N.M., Krueckl S.L., and McRory J.E. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev 21 (2000) 619-670
23. Somogyvari-Vigh A., and Reglodi D. Pituitary adenylate cyclase-activating polypeptide: a potential neuroprotective peptide. Curr Pharm Des 10 (2004) 2861-2889
24. Suzuki R., Arata S., Nakajo S., Ikenaka K., Kikuyama S., and Shioda S. Expression of the receptor for pituitary adenylate cyclase-activating polypeptide (PAC1-R) in reactive astrocytes. Brain Res Mol Brain Res 115 (2003) 10-20
25. Tanaka J., Koshimura K., Murakami Y., Sohmiya M., Yanaihara N., and Kato Y. Neuronal protection from apoptosis by pituitary adenylate cyclase-activating polypeptide. Regul Pept 72 (1997) 1-8
26. Vaudry D., Gonzalez B.J., Basille M., Yon L., Fournier A., and Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 52 (2000) 269-324
27. Vaudry D., Pamantung T.F., Basille M., Rousselle C., Fournier A., Vaudry H., et al. PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis. Eur J Neurosci 15 (2002) 1451-1460
28. Villalba M., Bockaert J., and Journot L. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. J Neurosci 17 (1997) 83-90
29. Zhou C.J., Yada T., Kohno D., Kikuyama S., Suzuki R., Mizushima H., et al. PACAP activates PKA, PKC and Ca(2+) signaling cascades in rat neuroepithelial cells. Peptides 22 (2001) 1111-1117
30. Zusev M., and Gozes I. Differential regulation of activity-dependent neuroprotective protein in rat astrocytes by VIP and PACAP. Regul Pept 123 (2004) 33-41